Clinical Trial Update: The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of OM-89 in patients with recurrent chronic prostatitis and chronic pelvic pain syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain Syndrome
• Prostatitis
• Prostatitis with Chronic Pelvic Pain Syndrome

Drugs mentioned

• OM-89 (Escherichia coli lysate OM-89)

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis | Phase 4 | Status: RECRUITING